Latest filings (excl ownership)
UPLOAD
Letter from SEC
12 Apr 11
15-12B
Securities registration termination
9 Nov 10
15F-12B
Securities registration termination (foreign)
4 Nov 10
EFFECT
Notice of effectiveness
1 Nov 10
EFFECT
Notice of effectiveness
1 Nov 10
POS AM
Prospectus update (post-effective amendment)
29 Oct 10
POS AM
Prospectus update (post-effective amendment)
29 Oct 10
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Oct 10
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Oct 10
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Oct 10
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Oct 10
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Oct 10
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Oct 10
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Oct 10
25
Voluntary exchange delisting
25 Oct 10
8-K
Penwest Pharmaceuticals Announces Intention to Terminate Nasdaq Listing and Registration
15 Oct 10
CT ORDER
Confidential treatment order
14 Oct 10
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7 Oct 10
UPLOAD
Letter from SEC
5 Oct 10
8-K
Penwest Pharmaceuticals Sets Special Shareholders Meeting Date for Approval of Merger with Subsidiary of Endo Pharmaceuticals
1 Oct 10
DEF 14A
Definitive proxy
1 Oct 10
CORRESP
Correspondence with SEC
24 Sep 10
PRER14A
Preliminary revised proxy
24 Sep 10
8-K
Changes in Control of Registrant
20 Sep 10
SC TO-T/A
Third party tender offer statement (amended)
20 Sep 10
UPLOAD
Letter from SEC
15 Sep 10
PREM14A
Preliminary proxy related to merger
7 Sep 10
SC 14D9/A
Tender offer solicitation (amended)
7 Sep 10
SC TO-T/A
Third party tender offer statement (amended)
7 Sep 10
SC 14D9/A
Tender offer solicitation (amended)
3 Sep 10
SC TO-T/A
Third party tender offer statement (amended)
3 Sep 10
CT ORDER
Confidential treatment order
20 Aug 10
SC 14D9
Tender offer solicitation
20 Aug 10
SC TO-T
Third party tender offer statement
20 Aug 10
SC TO-C
Information about tender offer
13 Aug 10
SC TO-C
Information about tender offer
12 Aug 10
8-K
Penwest Pharmaceuticals Agrees to Be Acquired by Endo Pharmaceuticals for $5.00 Per Share In Cash
10 Aug 10
SC14D9C
Written communication relating to third party tender offer
9 Aug 10
10-Q
2010 Q2
Quarterly report
6 Aug 10
8-K
Penwest Reports Record Revenue and Earnings for Second Quarter of 2010
4 Aug 10
Latest ownership filings
SC 13D/A
PERCEPTIVE ADVISORS LLC
27 Sep 10
SC 13D/A
TANG CAPITAL PARTNERS LP
27 Sep 10
SC 13D
ENDO PHARMACEUTICALS HOLDINGS INC
20 Sep 10
SC 13D/A
PERCEPTIVE ADVISORS LLC
23 Aug 10
SC 13D/A
PERCEPTIVE ADVISORS LLC
11 Aug 10
SC 13D/A
TANG CAPITAL PARTNERS LP
10 Aug 10
SC 13D/A
PERCEPTIVE ADVISORS LLC
1 Jul 10
SC 13D/A
TANG CAPITAL PARTNERS LP
30 Jun 10
11-K
Annual report of employee stock purchases
17 Jun 10
SC 13D/A
TANG CAPITAL PARTNERS LP
28 May 10
SC 13D/A
PERCEPTIVE ADVISORS LLC
28 May 10
SC 13D/A
PERCEPTIVE ADVISORS LLC
5 Feb 10
SC 13D/A
TANG CAPITAL PARTNERS LP
5 Feb 10
11-K
Annual report of employee stock purchases
26 Jun 09
11-K
Annual report of employee stock purchases
26 Jun 08
11-K
Annual report of employee stock purchases
28 Jun 07
11-K
Annual report of employee stock purchases
29 Jun 06
11-K
Annual report of employee stock purchases
29 Jun 05
11-K
Annual report of employee stock purchases
28 Jun 04
11-K
Annual report of employee stock purchases
27 Jun 03
11-K
Annual report of employee stock purchases
1 Jul 02
11-K
Annual report of employee stock purchases
29 Jun 01
11-K
Annual report of employee stock purchases
28 Jun 00
11-K
Annual report of employee stock purchases
29 Jun 99